Alex is a registered patent attorney who advises clients on matters pertaining to patent prosecution and patent portfolio management. He provides guidance to clients on developing portfolios for critical assets, and helps devise strategies for expanding protections on existing portfolios. Alex regularly performs prior art, landscape, and freedom-to-operate searches as part of his evaluation of patentability and freedom-to-operate issues, and prepares patentability, validity, and freedom-to-operate opinions for portfolio analyses and investment due diligence.

Alex has prepared and prosecuted patent applications for both public institutions and private pharmaceutical companies. In addition, he has managed patent portfolios for a variety of clients, prepared patentability and freedom-to-operate opinions for venture capital groups, and assisted in the development of a new product in the personalized medicine space for a medical technology provider. Although his practice focuses primarily on chemistry — including pharmaceuticals, chemicals (organic, inorganic, and organometallic), materials, and polymers — Alex also has experience with biotechnology (assays, PCR), polymeric drug delivery methods, fuel cell materials, and nanotechnology.

Alex’s PhD research focused on the rational design of new materials for nanometer scale imaging, and included the design and synthesis of small molecules and functional macromolecules for use in studies for nanoscale patterning.